Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech

Fidelity offers lower costs and steadier returns, while State Street targets smaller biotech companies with higher volatility and recent outperformance.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

Foreign Investors Sell More Than 20 Trillion Won in KOSPI Shares

Foreign investors have offloaded more than 20 trillion won worth of shares on the KOSPI over the past month, sharply cutting their exposure to the domestic equity market.

  • Foreign investors sold over 20 trillion won worth of KOSPI shares in September and October.
  • Selling pressure was relentless, with foreign investors buying only on seven out of 22 trading days.

More from Monday 5 October →